An acute infection of the skin caused by species of STREPTOCOCCUS. This disease most frequently affects infants, young children, and the elderly. Characteristics include pink-to-red lesions that spread rapidly and are warm to the touch. The commonest site of involvement is the face.
Networked: 391 relevant articles (24 outcomes, 26 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Cellulitis
3. Convalescence
4. Lymphedema (Milroy Disease)
5. Inflammation


1. Cussler, K: 5 articles (01/2002 - 01/2001)
2. Rosskopf-Streicher, U: 4 articles (01/2002 - 01/2001)
3. Linder, Adam: 3 articles (01/2014 - 05/2010)
4. Bernard, Philippe: 3 articles (04/2008 - 10/2002)
5. Bernard, P: 3 articles (05/2003 - 03/2001)
6. Johannes, S: 3 articles (01/2002 - 01/2001)
7. Saka, B: 2 articles (11/2015 - 04/2011)
8. Pitché, P: 2 articles (11/2015 - 04/2011)
9. Boukari, T: 2 articles (11/2015 - 04/2011)
10. Ly, F: 2 articles (11/2015 - 12/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Erysipelas:
1. VaccinesIBA
2. Penicillins (Penicillin)FDA Link
3. Penicillin G (Benzylpenicillin)FDA LinkGeneric
4. RoxithromycinIBA
5. AntigensIBA
6. Bacterial VaccinesIBA
7. Anti-Bacterial Agents (Antibiotics)IBA
8. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/01/2010 - "In erysipelas patients with a TNF-alpha value of 2.5 pg/ml or less at the onset of the disease, the relative risk for prolonged signs of systemic and local inflammatory reactions increases as compared with those who have a TNF-alpha level of more than 2.5 pg/ml."
03/01/2010 - "Prior infections were as follows: septicemia, n=2; lower respiratory tract infection or lung abscess, n=12; prosthesis infection, n=3; septic arthritis, n=3; endocarditis, n=1; pyelonephritis, n=2; osteitis, n=4; and various skin infections (erysipelas, cellulitis or skin abscess), n=6. Of these 33 infections, 21 occurred during TNFalpha antagonist therapy. "
05/01/2011 - "The aim of the investigation was to study the implication of infectious endotoxicosis in the pathogenesis of erysipelas, by measuring the level of malondialdehyde and the proinflammatory cytokine tumor necrosis factor-a (TNF-a) depending on the stage, severity, pattern of the disease, and possible complications. "
02/01/2010 - "The time course of changes in the values of proinflammatory tumor necrosis factor-alpha (TNF-alpha) and IL-8 and the anti-inflammatory cytokine IL-4 has been studied in 78 patients with erysipelas of different frequencies and pathomorphological forms of the disease. "
02/01/2010 - "In erysipelas and its erythematous form, there is an increase in the levels of TNF-alpha and IL-8 in early phase of the disease, a decrease in these indices during convalescence, and a rise in the content of the cytokine IL-4, which are typical of an acute cyclic infectious process with a good outcome. "
9. Erythema elevatum diutinumIBA
10. Prednisolone (Predate)FDA LinkGeneric

Therapies and Procedures

1. Antibiotic Prophylaxis
2. Aftercare (After-Treatment)
3. Radiotherapy
4. Lasers (Laser)
5. Subcutaneous Injections